Terminology Service for NFDI4Health
gp100:209-217 Peptide
Go to external page
http://purl.obolibrary.org/obo/NCIT_C2766
A synthetic peptide vaccine consisting of the amino acids 209 through 217 of the glycoprotein 100 (gp100) melanoma antigen. Vaccination with gp100_209-217 may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for gp100, resulting in decreased tumor growth. (NCI04) [ ]
Term info
Label
gp100:209-217 Peptide
Synonyms
- G9-209
- gp100:209-217 Peptide
Has Target
http://purl.obolibrary.org/obo/NCIT_C2386
Legacy Concept Name
gp100_209-217
NSC Code
676541
Preferred Name
gp100:209-217 Peptide
Semantic Type
Pharmacologic Substance, Amino Acid, Peptide, or Protein
UMLS CUI
C1515631
code
C2766
Term relations
Subclass of:
- Peptide Vaccine
- Chemical_Or_Drug_Has_Physiologic_Effect some T-Cell Activation
- Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some Cytotoxic T-Lymphocyte
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Antigen Sensitization
- Chemical_Or_Drug_Affects_Abnormal_Cell some Melanoma Cell
- Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation